Singapore, 30 November 2011 ‐ Biosensors International Group, Ltd. (“Biosensors”, “Company”, Bloomberg: BIG SP) today announced Wellford Capital Limited, a wholly‐owned subsidiary of Weigao International Medical Co. Limited, which is in turn a wholly‐owned subsidiary of Shandong Weigao Group Medical Polymer Company Limited (“Shandong Weigao”) has fully exercised its rights in converting the US$120 million principal amount of 4% convertible notes due 2014 held in Biosensors.
As a result, Shandong Weigao will become the single largest shareholder of Biosensors with 370 million shares, or approximately 21.6% of the Company.
----------------
Createwealth8888:
due 2014. Why convert so early?
Flash Deal: Get an HSBC Card, Get Nintendo Switch 2!!
-
Switch 2 is finally upon us, and even better — you can get a set entirely
free provided you apply for an HSBC credit card below as a new cardholder
and b...
4 hours ago
No comments:
Post a Comment